| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/ARRD.1985.131.4.493 |
| P698 | PubMed publication ID | 3922267 |
| P2093 | author name string | A Pelletier | |
| E Weitzenblum | |||
| A Sautegeau | |||
| M Ehrhart | |||
| M Mammosser | |||
| P433 | issue | 4 | |
| P921 | main subject | patient | Q181600 |
| chronic obstructive pulmonary disease | Q199804 | ||
| pulmonary hypertension | Q1128595 | ||
| oxygen therapy | Q1988216 | ||
| P304 | page(s) | 493-498 | |
| P577 | publication date | 1985-04-01 | |
| P1433 | published in | The American Review of Respiratory Disease | Q26839505 |
| P1476 | title | Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease | |
| P478 | volume | 131 |
| Q45423864 | Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial |
| Q41133442 | Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen |
| Q36176716 | Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema? |
| Q37103712 | Cardiac disease in chronic obstructive pulmonary disease |
| Q34170477 | Chronic cor pulmonale |
| Q36724123 | Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study |
| Q74600554 | Clinical classification of pulmonary hypertension |
| Q36237966 | Clinical features of patients on home oxygen therapy due to chronic respiratory failure at one university hospital |
| Q37187000 | Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. |
| Q35535817 | Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. |
| Q22299234 | Cor pulmonale |
| Q51693204 | Current therapeutic approaches to pulmonary arterial hypertension. |
| Q40990433 | Current thoughts regarding treatment of chronic obstructive pulmonary disease |
| Q42748542 | Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease |
| Q35563744 | Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia |
| Q36013670 | Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema |
| Q36817403 | Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension |
| Q34030827 | Evaluation of oxygen prescription in relation to hospital admission rate in patients with chronic obstructive pulmonary disease. |
| Q73227655 | Functional and oximetric assessment of patients after lung reduction surgery |
| Q61895125 | Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar |
| Q44194164 | Health-related quality of life in patients under long-term oxygen therapy: a home-based descriptive study |
| Q37383732 | Heliox-Driven Nebulization Has a Positive Effect on the Lung Function in Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease Rat Model |
| Q40941864 | Home oxygen therapy |
| Q41611557 | Home oxygen therapy |
| Q42850633 | Long-Term Home Oxygen Therapy: A rational approach. |
| Q37937464 | Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance |
| Q68194067 | Long-term Oxygen Therapy When to Leave Well Enough Alone |
| Q48932557 | Long-term oxygen therapy in patients with diagnoses other than COPD. |
| Q24647988 | Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report |
| Q38111714 | Lung transplantation and lung volume reduction surgery |
| Q38538687 | Management of Pulmonary Hypertension in Patients with Chronic Lung Disease |
| Q27005858 | Managing comorbidities in COPD |
| Q41650350 | NO: COPD and beyond |
| Q48944675 | Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients |
| Q35412362 | Overview of current therapeutic approaches for pulmonary hypertension. |
| Q24619439 | Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial |
| Q58713008 | Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension |
| Q52679946 | Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia. |
| Q26738405 | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
| Q36221051 | Pulmonary Hypertension Secondary to COPD. |
| Q37071014 | Pulmonary hypertension and chronic cor pulmonale in COPD |
| Q36859451 | Pulmonary hypertension associated with COPD. |
| Q38810145 | Pulmonary hypertension associated with lung diseases and hypoxemia |
| Q37973539 | Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. |
| Q61810184 | Pulmonary hypertension in chronic lung disease and hypoxia |
| Q58804546 | Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery |
| Q37523851 | Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management |
| Q67914799 | Pulmonary hypertension induced by amosite asbestos: A physiological and morphologic study in the guinea pig |
| Q35192891 | Pulmonary hypertension: work in progress |
| Q36179108 | Pulmonary vascular structure and function in chronic obstructive pulmonary disease |
| Q26749309 | Pulmonary vasculature in COPD: The silent component |
| Q40829767 | Recognition and management of pulmonary hypertension |
| Q35578998 | Recommendations on the management of pulmonary hypertension in clinical practice |
| Q41150471 | Reversal of hypoxia in a patient with chronic obstructive pulmonary disease, pulmonary hypertension, and oedema during treatment with long term domiciliary oxygen |
| Q33876337 | Right heart functional changes in the acute, hypercapnic exacerbations of COPD. |
| Q37822470 | Should patients have cardiac catheterization prior to long-term oxygen treatment? |
| Q73820406 | Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemia |
| Q36779343 | Tackling COPD: a multicomponent disease driven by inflammation |
| Q37687190 | The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension |
| Q51704944 | The heart in cystic fibrosis. |
| Q42504171 | Vasodilators in pulmonary hypertension |
| Q34999736 | Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs |
| Q82707721 | [COPD and pulmonary hypertension] |
| Q51158797 | [Comorbidities in COPD]. |
| Q80133380 | [Prognostic factors in chronic obstructive pulmonary disease] |
| Q82707696 | [Prognostic markers of COPD. Role of comorbidity] |
| Q72609280 | [Transtracheal catheter and liquid oxygen: 5 years of experience] |
Search more.